POSEIDA THERAPEUTICS INC.

In News

Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. - PR Newswire

PR Newswire - Nov 26, 2024

Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion - WSJ

WSJ - Nov 26, 2024

Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida - Reuters

Reuters - Jan 08, 2025

Roche Nears Completion of Poseida Acquisition Worth Up to $1.5B - BioSpace

BioSpace - Nov 26, 2024

Poseida Therapeutics’ Allogeneic CAR-T P-BCMA-ALLO1 Demonstrates 91% ORR in Enhanced Lymphodepletion Arm of R/R MM Study - CGTLive®

CGTLive® - Oct 10, 2024

Ikena Oncology and Inmagene Biopharmaceuticals Announce - GlobeNewswire

GlobeNewswire - Jul 23, 2025

Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Yahoo Finance - Dec 13, 2024

Major pharmaceutical company Roche buys cell and gene developer Poseida Therapeutics in $1.5 billion acquisition - BioProcess International

BioProcess International - Jan 08, 2025

Roche Inks Deal to Acquire Poseida Therapeutics - Pharmaceutical Executive

Pharmaceutical Executive - Dec 02, 2024

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy - PR Newswire

PR Newswire - Aug 07, 2023

Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies - PR Newswire

PR Newswire - Aug 03, 2022

Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline - PR Newswire

PR Newswire - Nov 14, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment